- The COVID-19 vaccine rollout roadmap has determined the phases of vaccination for priority groups.
- Learn more at the Department of Health’s COVID-19 vaccines website and subscribe to the COVID-19 Vaccines Update.
- Subscribe to our COVID-19 newsletter
- Read COVID-19 vaccine information in your language (Australian Government Department of Health)
- View SEMPHN’s COVID-19 webinar recordings
COVID-19 Vaccination Training Program
- AstraZeneca Training Package
- For training modules from the Department of Health (National COVID-19 Vaccination Training Program) click here.
- For modules to consolidate and evaluate your technical skills, access education via Melbourne Vaccine Education Centre (Victorian COVID-19 eLearning Competency), here.
This section aims to include relevant safety updates as they relate to the COVID-19 vaccines.
To see all of the Australian Technical Advisory Group on Immunisation (ATAGI)'s updates, click here.
From 17 June 2021:
ATAGI statement on revised recommendations on the use of COVID-19 Vaccine AstraZeneca:
From 9 June 2021:
From 26 May 2021:
COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) reviews cases of mild myocarditis reported with COVID-19 mRNA vaccines. Access the statement here.
From 23 May 2021:
ATAGI has released a joint statement with the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), providing updated information about TTS and the use of the AstraZeneca vaccine. The statement also provides an expanded list of people who can receive the AstraZeneca vaccine.
The risk of TTS is not likely to be increased in people with the following conditions, and people in these groups can receive COVID-19 Vaccine AstraZeneca:
The list of conditions for which Comirnaty (Pfizer) is the preferred vaccine has been expanded to also include:
TTS can be treated effectively. Guidance on the identification and management of TTS is available from the Thrombosis and Haemostasis Society of Australia and New Zealand.
21 April 2021:AstraZeneca Training Package
8 April 2021: ATAGI released a statement
ATAGI updated their resources to include information for health professionals and consumers about this clotting condition:
From 25 March 2021: ATAGI released a statement recommending deferral of vaccination with any COVID-19 vaccine for people who have a history of the below conditions:
Vaccine Rollout Schedule
- Read the updated vaccine rollout schedule as of 14 March 2021.
- The COVID-19 vaccine rollout has begun across Australia. We are currently in Phase 1b of the rollout.
Vaccine Rollout: Phase 1a
The COVID-19 vaccine rollout has begun across Australia.
The priority groups in this phase are:
- Quarantine and border workers
- Frontline health care worker sub-groups
- Aged care and disability care staff
- Aged care and disability residents
Use the eligibility checker to see find our when you or your patients can receive a COVID-19 vaccine.
On Monday 22 February, Residential Aged Care Facilities (RACF) began to receive vaccine supplies, starting the vaccination process for those in aged care.
The Department of Health has published a readiness toolkit for residential aged care facilities to help prepare for the roll-out of COVID-19 vaccines and obtaining and recording consent for residents. Information about reporting adverse events will be available soon along with more resources for providers, workers and residents.
Providers have an important role in the COVID-19 vaccine program.
Facilities will need to:
- provide information to residents and workers
- facilitate resident consent
- prepare their facility for vaccination day
- monitor and report adverse events.
- COVID-19 vaccine information for disability service providers
- COVID-19 Vaccine Dose Policy Guidance
- Read the readiness toolkit for RACFs.
- Read information for aged care providers/workers.
- Read the decision guide: Help older Australians make informed decisions about the COVID-19 vaccination.
Vaccine Rollout: Phase 1b
Update: 16 April 2021:
Information on indemnity, the rural and remote vaccine rollout, the delay in the delivery of vaccine consumables and seconds doses in residential aged care facilities.
Access the document here.
General Practice Expression of Interest (EOI) for Phase 1b
Accredited General Practices were invited to express their interest in participating in Phase 1b of the Australian Government’s COVID-19 Vaccine Roll-out from March 2021. The expression of interest is now closed.
Timeline of events:
- End February 2021: Letters were sent by email (from SEMPHN) to both eligible and non-eligible general practices at the end of February 2021, on behalf of the Commonwealth Department of Health.
- Friday 5 March: Letters were sent by email (from SEMPHN) to eligible General Practices, containing further detail on how and when these general practices will be involved in Phase 1b of the COVID Vaccine Rollout, as well as an Onboarding Pack.
Recommended information regarding the EOI
- Frequently Asked Questions - version 1
- Frequently Asked Questions - version 2
- Read the supporting documentation here.
Medical conditions covered under Phase 1b
- Read preliminary advice on identifying priority groups for the COVID-19 vaccine (ATAGI)
- Read how to identify if a person is at high risk of severe illness from COVID-19 (Australian Government Department of Health)
Information for Aboriginal and Torres Strait Islander peoples
- Click here.
Vaccine rollout: Phase 2a
States and territories began vaccinating people in Phase 2a in May 2021 starting with all adults 50 years and over.
- From 3 May 2021, people 50 years and over can receive the AstraZeneca vaccine at Commonwealth Vaccination and state and territory vaccination clinics.
- From 17 May 2021, people 50 years and over can receive the AstraZeneca vaccine at a participating general practice.
- From 28 May 2021 Victorians aged 40-49 years will be able to access the Pfizer vaccine at state-run vaccination sites, in line with advice from ATAGI. Read the Premier's statement.
- From 22 June 2021, the Australian Government introduced two new MBS items (10660 and 10661) to support General Practitioners and Other Medical Practitioners to provide in-depth clinical assessments of patients aged 50 years and over regarding patients’ individual health risks and benefits associated with receiving a COVID-19 vaccine. Further information: Item descriptors and Fact Sheet.
Influenza and COVID-19 Vaccination Advice
The Australian Technical Advisory Group on Immunisation (ATAGI) have provided advice on the relative timing of administering influenza and COVID-19 vaccines in 2021.
- Routine scheduling and giving of an influenza vaccine with a COVID-19 vaccine on the same day is not recommended.
- The preferred minimum interval between a dose of seasonal influenza vaccine and a dose of Pfizer/BioNTech or AstraZeneca/University of Oxford is 14 days.
- There may be circumstances where co-administration or near administration (within days) of an influenza vaccine with a COVID-19 vaccine may be considered.
- There is no particular requirement regarding the order of receiving a dose of influenza vaccine and either the first or second dose of a COVID-19 vaccine.
- If an influenza vaccine has been inadvertently co-administered or given within a shorter interval than 14 days with a COVID-19 vaccine, revaccination with either vaccine is not considered necessary.
For further information, please download the publication here.
Community engagement resources
Looking for COVID vaccine resources to share with colleagues, consumers, family and friends?
The Department of Health has a comprehensive suite of resources on their website, including videos, posters, social media content and radio ads.
Resources in multiple languages are also available. All resources are available to download and share and are regularly updated as the rollout continues. More videos targeting CALD communities will be available in April, which will tackle vaccine misinformation.
See the COVID-19 Vaccines Multicultural Outreach stakeholder pack (March 2021).
The Department of Health is coordinating the vaccine rollout for ACCHOS. Details can be found on their website:
- Information for COVID-19 vaccination providers (including ACCHOs)
- Information for Aboriginal and Torres Strait Islander peoples about COVID-19 vaccines
The Department has developed a suite of resources specifically for Aboriginal and Torres Strait Islander people.
These include an engagement kit, posters, suggested newsletter articles, social media posts and videos. These are updated as new information around dates, etc are confirmed.
South Eastern Melbourne PHN acknowledges the traditional custodians of the land our catchment covers, the Boon Wurrung and Wurundjeri people. We pay respect to them, their culture and their Elders past, present and future, and uphold their relationship to this land.
While the Australian Government Department of Health has contributed to the funding of this website, the information on this website does not necessarily reflect the views of the Australian Government and is not advice that is provided, or information that is endorsed, by the Australian Government. The Australian Government is not responsible in negligence or otherwise for any injury, loss or damage however arising from the use of or reliance on the information provided on this website.